HHGC
FSTX

Hunting Hill Global Capital’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Hunting Hill Global Capital’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,300
Closed -$14.5K – 110
2022
Q4 		$14.5K Buy
2,300
+800
+53% +$4.43K 0.01% 68
2022
Q3 		$8K Buy
+1,500
New +$9.42K ﹤0.01% 71

Hunting Hill Global Capital's FSTX Position: Q1 2023 in Review

Hunting Hill Global Capital sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 14,767 shares — an estimated $93.3K sold.

Hunting Hill Global Capital first reported a position in FSTX in Q3 2022 and held it in 2 quarters. The position peaked at $137K in Q3 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Hunting Hill Global Capital reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Hunting Hill Global Capital sold 14,767 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $93.3K.
  • Hunting Hill Global Capital first reported a position in F-star Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Hunting Hill Global Capital's F-star Therapeutics, Inc. Common Stock position peaked at $137K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Hunting Hill Global Capital's 13F filing for Q1 2023, filed 15 May 2023.